Usages in wwPDB of concept: c_0291
nUsages: 46; SSE string: EEHEEEEEE
4hf5:L     (PRO8) to    (GLY77)  CRYSTAL STRUCTURE OF FAB 8F8 IN COMPLEX A H2N2 INFLUENZA VIRUS HEMAGGLUTININ  |   VIRAL PROTEIN/IMMUNE SYSTEM, HEMAGGLUTININ, ANTIBODY, VIRAL RECEPTOR BINDING, ANTIGEN BINDING, SIALIC ACID, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
3t0x:A     (SER9) to    (GLY77)  FLUOROGEN ACTIVATING PROTEIN M8VLA4(S55P) IN COMPLEX WITH DIMETHYLINDOLE RED  |   IMMUNOGLOBULIN FOLD, FLUOROGEN ACTIVATION, DIMETHYLINDOLE RED, DYE- BINDING PROTEIN 
3gbm:M     (PRO8) to    (GLY77)  CRYSTAL STRUCTURE OF FAB CR6261 IN COMPLEX WITH A H5N1 INFLUENZA VIRUS HEMAGGLUTININ.  |   HEMAGGLUTININ, FAB, NEUTRALIZING ANTIBODIES, ANTIBODY, AVIAN FLU, ENVELOPE PROTEIN, FUSION PROTEIN, VIRAL PROTEIN - IMMUNE SYSTEM COMPLEX 
3gbn:L    (VAL11) to    (GLY77)  CRYSTAL STRUCTURE OF FAB CR6261 IN COMPLEX WITH THE 1918 H1N1 INFLUENZA VIRUS HEMAGGLUTININ  |   HEMAGGLUTININ, FAB, NEUTRALIZING ANTIBODIES, ANTIBODY, PANDEMIC FLU, CELL MEMBRANE, ENVELOPE PROTEIN, FUSION PROTEIN, GLYCOPROTEIN, LIPOPROTEIN, MEMBRANE, PALMITATE, TRANSMEMBRANE, VIRION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
3tnn:L    (SER10) to    (GLY77)  CRYSTAL STRUCTURE OF N5-I5 FAB, AN ADCC MEDIATING AND NON-NEUTRALIZING CD4I ANTI-HIV- 1 ANTIBODY.  |   ANTI-HIV-1 ENV ANTIBODY N5-I5, CD4I ANTIBODY, ADCC, HIV-1 ENV, IMMUNE SYSTEM 
3tnn:B    (SER10) to    (GLY77)  CRYSTAL STRUCTURE OF N5-I5 FAB, AN ADCC MEDIATING AND NON-NEUTRALIZING CD4I ANTI-HIV- 1 ANTIBODY.  |   ANTI-HIV-1 ENV ANTIBODY N5-I5, CD4I ANTIBODY, ADCC, HIV-1 ENV, IMMUNE SYSTEM 
3tnn:D    (SER10) to    (GLY77)  CRYSTAL STRUCTURE OF N5-I5 FAB, AN ADCC MEDIATING AND NON-NEUTRALIZING CD4I ANTI-HIV- 1 ANTIBODY.  |   ANTI-HIV-1 ENV ANTIBODY N5-I5, CD4I ANTIBODY, ADCC, HIV-1 ENV, IMMUNE SYSTEM 
3tnn:F    (SER10) to    (GLY77)  CRYSTAL STRUCTURE OF N5-I5 FAB, AN ADCC MEDIATING AND NON-NEUTRALIZING CD4I ANTI-HIV- 1 ANTIBODY.  |   ANTI-HIV-1 ENV ANTIBODY N5-I5, CD4I ANTIBODY, ADCC, HIV-1 ENV, IMMUNE SYSTEM 
4yaq:L     (SER9) to    (GLY77)  CRYSTAL STRUCTURE OF A COMPUTATIONALLY OPTIMIZED PG9 MUTANT  |   ANTIBODY, HIV, IMMUNE SYSTEM 
4yaq:B     (SER9) to    (GLY77)  CRYSTAL STRUCTURE OF A COMPUTATIONALLY OPTIMIZED PG9 MUTANT  |   ANTIBODY, HIV, IMMUNE SYSTEM 
4m1d:L     (SER9) to    (GLY77)  CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 CYCLIC PEPTIDE MN  |   HIV, V3 LOOP, ANTIBODY-ANTIGEN INTERACTIONS, ENVELOPE, IMMUNE SYSTEM 
2ig2:L     (PRO8) to    (GLY76)  DIR PRIMAERSTRUKTUR DES KRISTALLISIERBAREN MONOKLONALEN IMMUNOGLOBULINS IGG1 KOL. II. AMINOSAEURESEQUENZ DER L- KETTE, LAMBDA-TYP, SUBGRUPPE I (GERMAN)  |   IMMUNOGLOBULIN 
5ado:L     (SER9) to    (GLY78)  CRYSTAL STRUCTURE OF THE PARAOXON-MODIFIED A.17 ANTIBODY FAB FRAGMENT - LIGHT CHAIN S35R MUTANT  |   IMMUNE SYSTEM, ENZYME REPROGRAMMING, ANTIBODIES, IG SUPERFAMILY, IN SILICO ANTIBODY MATURATION 
5adp:L     (PRO8) to    (GLY78)  CRYSTAL STRUCTURE OF THE A.17 ANTIBODY FAB FRAGMENT - LIGHT CHAIN S35R MUTANT  |   IMMUNE SYSTEM, ENZYME REPROGRAMMING, ANTIBODIES, IG SUPERFAMILY, IN SILICO ANTIBODY MATURATION 
4n0y:L     (SER9) to    (GLY77)  STRUCTURE OF THE HEPATITIS C ENVELOPE GLYCOPROTEIN E1 ANTIGENIC REGION 314-324 BOUND TO THE CROSS-NEUTRALIZING ANTIBODY IGH526  |   IMMUNOGLOBULIN FOLD, AMIDATED C-TERMINUS, IMMUNE SYSTEM 
4n1h:B     (GLN3) to    (ASN84)  STRUCTURE OF A SINGLE-DOMAIN CAMELID ANTIBODY FRAGMENT CAB-F11N IN COMPLEX WITH THE BLAP BETA-LACTAMASE FROM BACILLUS LICHENIFORMIS  |   IMMUNOGLOBULIN FOLD, ANTIGEN BINDING, HYDROLASE-IMMUNE SYSTEM COMPLEX 
2jb6:A     (ALA8) to    (GLY79)  FAB FRAGMENT IN COMPLEX WITH SMALL MOLECULE HAPTEN, CRYSTAL FORM-2  |   CDR, TSC, FAB, HUCAL, FLUORESCENT DYE, IMMUNOGLOBULIN DOMAIN, ANTIBODY FRAGMENT, DIAGNOSTIC IMAGING, IMMUNE SYSTEM 
2xza:L     (PRO8) to    (GLY78)  CRYSTAL STRUCTURE OF RECOMBINANT A.17 ANTIBODY FAB FRAGMENT  |   IMMUNE SYSTEM 
2xzc:L     (PRO8) to    (GLY78)  CRYSTAL STRUCTURE OF PHOSPHONATE-MODIFIED RECOMBINANT A.17 ANTIBODY FAB FRAGMENT  |   IMMUNE SYSTEM 
3zl4:L     (SER9) to    (GLY78)  ANTIBODY STRUCTURAL ORGANIZATION: ROLE OF KAPPA -  LAMBDA CHAIN CONSTANT DOMAIN SWITCH IN CATALYTIC FUNCTIONALITY  |   IMMUNE SYSTEM 
5c2b:L     (ALA8) to    (GLY79)  ANTI-CXCL13 PARENTAL SCFV - 3B4  |   ANTI-CXCL13, SCFV, IMMUNE SYSTEM 
5c6w:H  (ALA1008) to  (GLY1079)  ANTI-CXCL13 SCFV - E10  |   ANTI-CXCL13, SCFV, IMMUNE SYSTEM 
5c6w:J  (ALA1008) to  (GLY1079)  ANTI-CXCL13 SCFV - E10  |   ANTI-CXCL13, SCFV, IMMUNE SYSTEM 
5cbe:B     (ALA8) to    (GLY77)  E10 IN COMPLEX WITH CXCL13  |   ANTI-CXCL13, E10, SCFV, IMMUNE SYSTEM 
5cbe:D     (GLN1) to    (GLY77)  E10 IN COMPLEX WITH CXCL13  |   ANTI-CXCL13, E10, SCFV, IMMUNE SYSTEM 
4osu:L     (PRO8) to    (GLY78)  CRYSTAL STRUCTURE OF HCMV GB-NEUTRALIZING SM5-1 FAB FRAGMENT  |   IMMUNOGLOBULIN, IMMUNE RESPONSE, HCMV NEUTRALIZATION, HCMV GLYCOPROTEIN B, IMMUNE SYSTEM 
4aiz:B     (SER9) to    (GLY76)  CRYSTALLOGRAPHIC STRUCTURE OF 3MJL2 FROM THE GERMINAL LINE LAMBDA 3  |   IMMUNE SYSTEM, AMYLOIDOSIS 
4aiz:D     (PRO8) to    (GLY76)  CRYSTALLOGRAPHIC STRUCTURE OF 3MJL2 FROM THE GERMINAL LINE LAMBDA 3  |   IMMUNE SYSTEM, AMYLOIDOSIS 
3lmj:L     (SER9) to    (GLY78)  STRUCTURE OF HUMAN ANTI HIV 21C FAB  |   IMMUNOGLOBULIN, IMMUNE SYSTEM 
4qhl:B     (SER9) to    (GLY77)  I3.2 (UNBOUND) FROM CH103 LINEAGE  |   FAB FRAGMENT, HIV-1, ANTIBODY, IMMUNE SYSTEM 
4qhl:D     (SER9) to    (GLY77)  I3.2 (UNBOUND) FROM CH103 LINEAGE  |   FAB FRAGMENT, HIV-1, ANTIBODY, IMMUNE SYSTEM 
3mcg:1     (PCA1) to    (SER78)  THREE-DIMENSIONAL STRUCTURE OF A LIGHT CHAIN DIMER CRYSTALLIZED IN WATER. CONFORMATIONAL FLEXIBILITY OF A MOLECULE IN TWO CRYSTAL FORMS  |   IMMUNOGLOBULIN 
3muh:L     (ALA8) to    (GLY77)  CRYSTAL STRUCTURE OF PG9 LIGHT CHAIN  |   PG9, HIV, IMMUNE SYSTEM 
5f6h:J     (PRO8) to    (GLY79)  CRYSTAL STRUCTURE OF TIER 2 NEUTRALIZING ANTIBODY DH427 FROM A RHESUS MACAQUE  |   FAB FRAGMENT, HIV-1, ANTIBODY, IMMUNE SYSTEM 
3c2a:M     (SER9) to    (GLY77)  ANTIBODY FAB FRAGMENT 447-52D IN COMPLEX WITH UG1033 PEPTIDE  |   ANTIBODY FAB HIV-1 PEPTIDE, ENVELOPE PROTEIN, IMMUNE SYSTEM 
4rfo:L     (SER9) to    (GLY77)  CRYSTAL STRUCTURE OF THE ADCC-POTENT ANTIBODY N60-I3 FAB IN COMPLEX WITH HIV-1 CLADE A/E GP120 AND M48U1  |   HIV-1 GP120, CLADE A/E 93TH057, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM-INHIBITOR COMPLEX 
4dqo:L     (SER9) to    (GLY77)  CRYSTAL STRUCTURE OF PG16 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN ZM109  |   IMMUNOGLOBULIN, IMMUNE RECOGNITION, IMMUNE SYSTEM, GLYCAN, HIV-1, V1V2, ENVELOPE GLYCOPROTEIN 
4unv:A     (SER9) to    (GLY79)  COVALENT DIMER OF LAMBDA VARIABLE DOMAINS  |   IMMUNE SYSTEM, BENCE-JONES, IMMUNOGLOBULIN, AMYLOID 
4eow:L     (SER9) to    (GLY78)  CRYSTAL STRUCTURE OF A DISEASE-ASSOCIATED ANTI-HUMAN GM-CSF AUTOANTIBODY MB007  |   IMMUNSYSTEM, ALPHA-HELICAL STRETCH IN CDR3-H, PROTEIN-DOCKING, IMMUNOGLOBULIN IGG1 (LAMBDA), AUTOANTIBODY CAUSING PAP, GM-CSF, IMMUNE SYSTEM 
4f58:M     (SER9) to    (GLY77)  FAB STRUCTURE OF A NEUTRALIZING ANTIBODY L3 FROM AN EARLY SUBTYPE A HIV-1 INFECTED PATIENT  |   IG, ANTIBODY, GP120, IMMUNE SYSTEM 
4f58:N     (LEU4) to    (GLY77)  FAB STRUCTURE OF A NEUTRALIZING ANTIBODY L3 FROM AN EARLY SUBTYPE A HIV-1 INFECTED PATIENT  |   IG, ANTIBODY, GP120, IMMUNE SYSTEM 
4f58:O     (ALA8) to    (GLY77)  FAB STRUCTURE OF A NEUTRALIZING ANTIBODY L3 FROM AN EARLY SUBTYPE A HIV-1 INFECTED PATIENT  |   IG, ANTIBODY, GP120, IMMUNE SYSTEM 
3u2s:L     (SER9) to    (GLY77)  CRYSTAL STRUCTURE OF PG9 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN ZM109  |   GREEK KEY, IMMUNOGLOBULIN, IMMUNE RECOGNITION, IMMUNE SYSTEM 
3u2s:B     (ALA8) to    (GLY77)  CRYSTAL STRUCTURE OF PG9 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN ZM109  |   GREEK KEY, IMMUNOGLOBULIN, IMMUNE RECOGNITION, IMMUNE SYSTEM 
4nki:L     (ALA8) to    (GLY79)  CRYSTAL STRUCTURE OF A FAB  |   NONOCLONAL ANTIBODY, IMMUNOGLOBULIN, ANTIBODY, PD-L1, SOLUBLE PROTEIN, CYTOKINE 
4rav:B   (ALA135) to   (GLY206)  CRYSTAL STRUCTURE OF SCFVC4 IN COMPLEX WITH THE FIRST 17 AA OF HUNTINGTIN  |   IMMUNOGLOBULIN FOLD, IMMUNITY, 1-17 RESIDUES OF HUNTINGTIN, IMMUNE SYSTEM-APOPTOSIS COMPLEX